Objective To investigate the safety and effectiveness of automatic pacemaker in sick sinus syndrome. Methods Twenty-six patients with sick sinus syndrome were implanted automatic pacemaker, including 13 Enpluse E2D01, 6 Adapta ADDR01, 7 Kappa 701. Minimal ventricular pacing from pump function were closed in adapta AD-DR01. The pacemaker parameters were reviewed at 1,3 and 6 months after implantation. Results The follow-up of Enpluse , Adapta were completed for the automatic management of atrial pacing threshold. At 1, 3 and 6 months of follow-up, manual and automatic atrial threshold measurement were of no difference. All patients were followed up to complete automatic management of ventricular pacing thresholds. At 1, 3 and 6 months of follow-up, manual and automatic measurement of ventricular threshold had no difference too. Most cardiac events were perceived events. Conclusion Enpluse, Adapta, Kappa pacemaker automation is safe and effective.%目的 通过对病窦综合征患者植入自动化起搏器的随访,分析其心房自动阈值管理、心室自动阈值管理、自动房室间期搜索等功能的安全性和有效性.方法 选取病窦综合征26例,其中植入Enpluse E2D01起搏器13例、Adapta ADDR01起搏器6例、Kappa 701起搏器7例；植入时Adapta ADDR01起搏器关闭最小心室起搏功能；分别于起搏器植入后1,3,6个月时复查起搏器参数.结果 随访的Enpluse、Adapta起搏器病例均完成了心房起搏阈值自动管理；于1,3,6个月随访时,手动与自动测量的心房阈值无差异.所有随访的病例均完成心室起搏阈值自动管理；于1,3,6个月随访时,手动与自动测量心室阈值无差异.术后随访患者大部分心室事件为感知事件.结论 Enpluse、Adapta、Kappa起搏器的自动化功能安全、有效.
展开▼
